Author

Emiel Van Boxel

VIB-KU Leuven Center for Cancer BiologyORCID 0000-0003-0879-4530Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Anna A. SablinaiD· 1 shared Benoit Lechat· 1 shared Edward C. StitesiD· 1 shared Greetje Vande VeldeiD· 1 shared Peihua ZhaoiD· 1 shared Raj Nayan SewduthiD· 1 shared Tonči IvaniševićiD· 1 shared Wout MagitsiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anna A. SablinaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Increased dosage of wild-type KRAS protein drives KRAS-mutant lung tumorigenesis and drug resistance

Tonči Ivanišević, Wout Magits, Yan Ma, Peihua Zhao, Emiel Van Boxel, Benoit Lechat, Edward C. Stites, Greetje Vande Velde, Raj Nayan Sewduth, Anna A. Sablina

This study shows that increased wild-type KRAS protein dosage in KRAS-mutant lung cancer drives tumor growth and drug resistance, with vascular changes mediated by mTOR pathway activation.

bioRxiv · Feb 27, 2024 · PreprintCancer Biology